$225.96-1.23 (-0.54%)
IDEX Corporation, together with its subsidiaries, provides applied solutions in the United States, North America, Europe, Asia, and internationally.
IDEX Corporation in the Industrials sector is trading at $225.96 with a market capitalization of $15.9B. Wall Street consensus targets $238.29 (14 analysts), implying a +5.5% move over the next 12 months. The stock is currently near its 52-week high of $230.18, remaining 19.1% above its 200-day moving average. On fundamentals, Piotroski 8/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $886.90M↓ | $899.10M↑ | $878.70M↑ | $865.40M↑ | $814.30M |
| Gross Profit | $398.10M↑ | $387.10M↓ | $390.60M↓ | $392.20M↑ | $368.90M |
| Operating Income | $179.80M↓ | $186.00M | $185.90M↓ | $188.60M↑ | $159.50M |
| Net Income | $120.00M↓ | $128.30M↑ | $127.80M↓ | $131.60M↑ | $95.50M |
IDEX Corporation, together with its subsidiaries, provides applied solutions in the United States, North America, Europe, Asia, and internationally. It operates through three segments: Health & Science Technologies (HST), Fluid & Metering Technologie...
ALLE's Americas strength, acquisitions and shareholder returns support growth, though international weakness and rising costs remain.
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies — as Jeff Bezos said, “Your margin is my opportunity”.
Does Idex (IEX) have what it takes to be a top stock pick for momentum investors? Let's find out.
AIT gains from MRO demand, acquisitions and shareholder returns, but rising costs and supply-chain issues remain key risks.
While IDEX has outperformed relative to its peers over the past 52 weeks, Wall Street analysts remain cautiously optimistic about the stock’s prospects.